๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Areata Alopecia

Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome NCT07242638Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Abrocitinib Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration NCT07554222Phase 11 site๐Ÿ“ Shanghai Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: placebo, Baricitinib tablets, IBI3013 A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata NCT06873945Phase 3148 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Birmingham Pfizer ยท Tests: Ritlecitinib 100 mg, Ritlecitinib 50 mg, Placebo - 100 mg, Placebo - 50 mg A Study of LAD603 in Adults With Alopecia Areata NCT07311564Phase 21 site๐Ÿ“ Omaha Almirall, S.A. ยท Tests: LAD603, Placebo Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata NCT06747611Phase 21 site๐Ÿ“ Minneapolis University of Minnesota ยท Tests: Vancomycin, Neomycin and MTT capsules, Placebo capsules Regeneron AA Multicenter (Dupilumab) NCT05551793Phase 23 sites๐Ÿ“ Irvine๐Ÿ“ New York๐Ÿ“ Rochester Emma Guttman ยท Tests: Dupilumab, Placebo Dupilumab in the Treatment of Pediatric Alopecia Areata NCT05866562Phase 25 sites๐Ÿ“ Irvine๐Ÿ“ San Diego๐Ÿ“ Chicago Icahn School of Medicine at Mount Sinai ยท Tests: Dupilumab, Placebo PALLAS Laser for Skin Diseases NCT07250997NA1 site๐Ÿ“ Szeged Szeged University ยท Tests: UVB laser treatment Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study NCT07381556Phase 41 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: Methotrexate, Cyclosporin (CSA) A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata NCT07762443Phase 11 site๐Ÿ“ Beijing Jiangsu vcare pharmaceutical technology co., LTD ยท Tests: VC005 tablets Systemic Treatments for Alopecia Areata Registry NCT06283316n/a1 site๐Ÿ“ Rotterdam Erasmus Medical Center Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata NCT06104839Phase 22 sites๐Ÿ“ Seoul๐Ÿ“ Seoul NEXTGEN Bioscience ยท Tests: NXC736, Placebo HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata NCT07049328Phase 13 sites๐Ÿ“ Tampa๐Ÿ“ Indianapolis๐Ÿ“ Columbus HCW Biologics ยท Tests: HCW9302, an IL-2 fusion protein CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry NCT05745389n/a1 site๐Ÿ“ Waltham CorEvitas A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice. NCT07152119n/a1 site๐Ÿ“ Seoul Pfizer ยท Tests: Litfulo Determinants of Chronic Inflammatory Skin Disease Trajectories NCT05928169n/a1 site๐Ÿ“ Kiel University Hospital Schleswig-Holstein ยท Tests: Topical and systemic drugs Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia Areata NCT07733063n/a1 site๐Ÿ“ Istanbul Istanbul Training and Research Hospital A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) NCT07533006Phase 230 sites๐Ÿ“ Fremont๐Ÿ“ Northridge๐Ÿ“ Santa Clarita Eli Lilly and Company ยท Tests: LY4005130, Placebo A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa NCT07136467n/a116 sites๐Ÿ“ Ciudad Autonoma de Buenos Aire๐Ÿ“ Buenos Aires๐Ÿ“ Buenos Aires AbbVie A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata NCT05723198Phase 3127 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Scottsdale Eli Lilly and Company ยท Tests: Baricitinib, Placebo Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata NCT07749716Phase 21 site๐Ÿ“ Beijing Jiangsu vcare pharmaceutical technology co., LTD ยท Tests: Drug: VC005 tablets, VC005 tablets, VC005 placebo tablets A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata NCT07772492Phase 314 sites๐Ÿ“ Los Angeles๐Ÿ“ Miami๐Ÿ“ Meridian AbbVie ยท Tests: Upadacitinib, Placebo A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata NCT07733765Phase 338 sites๐Ÿ“ Encinitas๐Ÿ“ Miami๐Ÿ“ Skokie Pfizer ยท Tests: Ritlecitinib 100 mg, Ritlecitinib 50 mg, Placebo Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata NCT07617597Phase 318 sites๐Ÿ“ Asahikawa๐Ÿ“ Bunkyล City๐Ÿ“ Ebina Sun Pharma Japan Limited ยท Tests: Deuruxolitinib, Placebo Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata NCT06327581NA1 site๐Ÿ“ Zagazig Zagazig University ยท Tests: Lactic Acid, vit D, Triamcinolone Acetonide, Saline Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study NCT06573593n/a1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Tofacitinib, Baricitinib, Ruxolitinib, Upadacitinib, Abrocitinib A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata. NCT07029828Phase 367 sites๐Ÿ“ Irvine๐Ÿ“ Santa Ana๐Ÿ“ Aurora Pfizer ยท Tests: Ritlecitinib higher dose, Ritlecitinib lower dose CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry NCT06562270n/a1 site๐Ÿ“ Waltham CorEvitas A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata NCT06826196Phase 1, Phase 27 sites๐Ÿ“ Thousand Oaks๐Ÿ“ West Lafayette๐Ÿ“ Boston Aldena Therapeutics ยท Tests: ALD-102 Solution, Placebo or Control A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata. NCT07205159Phase 16 sites๐Ÿ“ Saint Leonards๐Ÿ“ Coorparoo๐Ÿ“ South Yarra Forte Biosciences, Inc. ยท Tests: FB102, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy